Vyome Holdings (HIND) Notes Payables (2015 - 2016)
Vyome Holdings (HIND) posted quarterly Notes Payables of $882000.0 for Q3 2016, up 165.66% quarter-over-quarter from $332000.0 in Q4 2015.
Vyome Holdings (HIND) Notes Payables (2015 - 2016) Analysis & Trends
Vyome Holdings' Notes Payables history runs 2 years deep, the most recent figure standing at $882000.0 for Q3 2016.
- In Q3 2016, Notes Payables changed N/A year-over-year to $882000.0; the TTM figure through Sep 2016 stood at $882000.0 (changed N/A YoY), while the FY2015 annual figure was $332000.0, changed N/A from the prior year.
- Notes Payables for Q3 2016 stood at $882000.0, up from $332000.0 in the prior quarter.
- The five-year high for Notes Payables was $882000.0 in Q3 2016, with the low at $332000.0 in Q4 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Vyome Holdings | 16.00 Mn | 8.11 Mn | 11,658.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2016 | 882,000.00 |
| Dec 31, 2015 | 332,000.00 |